[Treatment mostly not in line with current knowledge. New guidelines for sinusitis therapy].
D000208:Acute Disease / Q000628:therapy; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy*; D000077722:Ceftibuten; D002511:Cephalosporins / Q000627:therapeutic use*; D002908:Chronic Disease / Q000188:drug therapy; D019818:Clavulanic Acid / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple; D006801:Humans; D000068656:Mometasone Furoate; D010397:Penicillanic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011244:Pregnadienediols / Q000627:therapeutic use; D012852:Sinusitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D002511:Cephalosporins; D011244:Pregnadienediols; D000068656:Mometasone Furoate; D019818:Clavulanic Acid; D010397:Penicillanic Acid; D000077722:Ceftibuten; C004408:aminopenicillanic acid
Behandlung entspricht meist nicht dem aktuellen Wissensstand. Neue Leitlinien zur Sinusitis-Therapie.